PGF and colorectal cancer: Additional evidence for the efficacy of anti-angiogenic therapy in colorectal cancer comes from a study of aflibercept, a novel fusion protein that binds to three VEGF family ligands: VEGF-A, VEGF-B and placental growth factor (PLGF).